ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
37 hedge funds and large institutions have $6.37M invested in Anthera Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
6
Reduced
14
Closed
11
Calls
$985K
Puts
$111K
Net Calls
+$874K
Net Calls Change
+$447K
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.3M |
2 |
AC
Armistice Capital
New York
|
+$1.27M |
3 |
6CM
683 Capital Management
New York
|
+$399K |
4 |
BI
BVF Inc
San Francisco,
California
|
+$346K |
5 |
ARTA
A.R.T. Advisors
New York
|
+$58K |
Top Sellers
1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$155K |
2 |
Millennium Management
New York
|
-$87K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$82.4K |
4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$75K |
5 |
TSS
Two Sigma Securities
New York
|
-$63.7K |